Being equipped for clinical PET

被引：17

作者：

O'Doherty, MJ ^{[1
]}

Marsden, PK

机构：

[1] St Thomas Hosp, Guys Kings & St Thomas Sch Med, Dept Radiol Sci, London SE1 7EH, England

[2] St Thomas Hosp, Clin PET Ctr, London SE1 7EH, England

来源：

LANCET | 2000年 / 356卷 / 9243期

关键词：

D O I：

10.1016/S0140-6736(00)03200-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1701 / 1703

页数：3

共 17 条

[1]

Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.3.CO

[2]

2-#

[3]

Bakheet SM, 1998, SEMIN NUCL MED, V28, P352

[4] Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDC-PET) for accurate staging of Hodgkin's disease [J].

Bangerter, M ;

Moog, F ;

Buchmann, I ;

Kotzerke, J ;

Griesshammer, M ;

Hafner, M ;

Elsner, K ;

Frickhofen, N ;

Reske, SN ;

Bergmann, L .

ANNALS OF ONCOLOGY, 1998, 9 (10) :1117-1122

[5] Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine [J].

Cook, GJR ;

Maisey, MN ;

Fogelman, I .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (10) :1363-1378

[6]

Delbeke D, 1999, J NUCL MED, V40, P110

[7] Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany [J].

Dietlein, M ;

Weber, K ;

Gandjour, A ;

Moka, D ;

Theissen, P ;

Lauterbach, KW ;

Schicha, H .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (10) :1441-1456

[8]

Gambhir SS, 1996, J NUCL MED, V37, P1428

[9] Analytical decision model for the cost-effective management of solitary pulmonary nodules [J].

Gambhir, SS ;

Shepherd, JE ;

Shah, BD ;

Hart, E ;

Hoh, CK ;

Valk, PE ;

Emi, T ;

Phelps, ME .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2113-2125

[10]

Huebner RH, 2000, J NUCL MED, V41, P1177

← 1 2 →